Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesThe interface of pain and mood disturbances in the rheumatic diseases
Seminars in Arthritis and Rheumatism, 06/23/09
Goldenberg DL et al. – This review provides a basis for understanding the importance of the pain/depression interface in the rheumatic illnesses. Clinical and pathophysiologic studies in fibromyalgia (FM) demonstrate the striking overlap of pain and depression.
Methods- Aim was to review:
- Overlap of pain and depression in the rheumatic diseases, focusing on FM and RA, and
- To provide treatment recommendations based on an understanding of this interface
- A literature search was performed through PubMed and Medline, for the yrs 1978 to 2008
- Keywords used: depression, mood disorders, pain, arthritis, fibromyalgia, rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, scleroderma, antidepressants, exercise, and cognitive behavioral therapy
- Review focuses on the pain/depression interface in common rheumatic disorders; treatment principles are outlined as:
- Pain and depression are inseparable, bidirectional
- Explain to patients the shared neurobiology of pain and depression
- Always evaluate and treat sleep disturbances
- “Bundle” the treatment of mood disturbances with physical symptoms carefully
- Use diagnostic labels cautiously; avoid causation
- Avoid inactivity, fear-avoidance
- Neural pain dysregulation is prominent in all rheumatic diseases (FM model)
- General therapeutic recommendations can be made based on these overlapping models of the interface of pain and depression
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research , 11/03/09
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/26/09
Sponsor
Article Search
Sponsor